HEADER ANTIBIOTIC 12-APR-99 1QFI TITLE SYNTHESIS AND STRUCTURE OF PROLINE RING MODIFIED ACTINOMYCINS OF X TITLE 2 TYPE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTINOMYCIN X2; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: ACTINOMYCIN V; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: STREPTOMYCES ANTIBIOTICUS; SOURCE 4 ORGANISM_TAXID: 1890 KEYWDS ACTINOMYCIN, ANTICANCER, ANTITUMOR, CHROMOPHORE, DEPSIPEPTIDE, KEYWDS 2 ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR A.LIFFERTH,I.BAHNER,H.LACKNER,M.SCHAEFER REVDAT 6 15-NOV-23 1QFI 1 REMARK LINK ATOM REVDAT 5 04-OCT-17 1QFI 1 REMARK REVDAT 4 27-JUL-11 1QFI 1 REMARK REVDAT 3 13-JUL-11 1QFI 1 VERSN REVDAT 2 24-FEB-09 1QFI 1 VERSN REVDAT 1 15-JUL-03 1QFI 0 JRNL AUTH A.LIFFERTH,I.BAHNER,H.LACKNER,M.SCHAEFER JRNL TITL SYNTHESIS AND STRUCTURE OF PROLINE RING MODIFIED JRNL TITL 2 ACTINOMYCINS OF THE X-TYPE JRNL REF Z.NATURFORSCH. V. 54 681 1999 JRNL REFN ISSN 0341-0382 REMARK 2 REMARK 2 RESOLUTION. 0.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.065 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 15506 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.062 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 14554 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 273 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 310.80 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 307.60 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 9 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 2994 REMARK 3 NUMBER OF RESTRAINTS : 3955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.019 REMARK 3 ANGLE DISTANCES (A) : 0.000 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.027 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.124 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.000 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.000 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.000 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.030 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.056 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-APR-99. REMARK 100 THE DEPOSITION ID IS D_1000000828. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 153.00 REMARK 200 PH : 5.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS HI-STAR REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15506 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.910 REMARK 200 RESOLUTION RANGE LOW (A) : 25.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : 0.01500 REMARK 200 FOR THE DATA SET : 43.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.11500 REMARK 200 R SYM FOR SHELL (I) : 0.06600 REMARK 200 FOR SHELL : 14.70 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT METHODS REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 20.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTINOMYCIN X2 IS A BICYCLIC PEPTIDE, A MEMBER OF THE REMARK 400 ACTINOMYCIN FAMILY. REMARK 400 HERE, ACTINOMYCIN X2 IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE ACTINOMYCIN X2 IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACTINOMYCIN X2 REMARK 400 CHAIN: A, B, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: ACTINOMYCIN X2 CONSISTS OF TWO PENTAMER RINGS LINKED REMARK 400 BY THE CHROMOPHORE (PXZ) REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 34 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 35 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 37 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 38 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 40 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE C 36 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE C 41 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF ACTINOMYCIN X2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF ACTINOMYCIN X2 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ACTINOMYCIN X2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN Z3 REMARK 900 RELATED ID: 209D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N8-ACTINOMYCIN D COMPLEXED WITH D(GAAGCTTC)2 REMARK 900 RELATED ID: 1UNM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINOACTINOMYCIN D COMPLEXED WITH NON- REMARK 900 COMPLEMENTARY DNA REMARK 900 RELATED ID: 1I3W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CGATCGATCG)2 REMARK 900 RELATED ID: 1A7Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D REMARK 900 RELATED ID: 1FJA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (AAGCGCTT)2 REMARK 900 RELATED ID: 173D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 2D55 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1L1V RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTNIOMYCIN D COMPLEXED WITH MISMATCHED DNA REMARK 900 (GTCACCGAC) REMARK 900 RELATED ID: 316D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF F8-ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GATGCTTC)2 REMARK 900 RELATED ID: 1MNV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (ATGCTGCAT)2 REMARK 900 RELATED ID: 1UNJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINO-ACTINOMYCIN D COMPLEXED WITH A NON- REMARK 900 COMPLEMENTARY DNA (TTAGT)2 REMARK 900 RELATED ID: 1OVF RELATED DB: PDB REMARK 900 SOLUTIOM STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CCGTTTTGTGG) REMARK 900 2 DBREF 1QFI A 1 11 NOR NOR00232 NOR00232 1 11 DBREF 1QFI B 1 11 NOR NOR00232 NOR00232 1 11 DBREF 1QFI C 1 11 NOR NOR00232 NOR00232 1 11 SEQRES 1 A 11 THR DVA DPL SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 B 11 THR DVA DPL SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 C 11 THR DVA DPL SAR MVA PXZ THR DVA PRO SAR MVA HET DVA A 2 7 HET DPL A 3 8 HET SAR A 4 5 HET MVA A 5 8 HET PXZ A 6 22 HET DVA A 8 7 HET SAR A 10 5 HET MVA A 11 8 HET DVA B 2 7 HET DPL B 3 8 HET SAR B 4 5 HET MVA B 5 8 HET PXZ B 6 22 HET DVA B 8 7 HET SAR B 10 5 HET MVA B 11 10 HET DVA C 2 7 HET DPL C 3 8 HET SAR C 4 5 HET MVA C 5 8 HET PXZ C 6 22 HET DVA C 8 7 HET SAR C 10 5 HET MVA C 11 8 HET EEE A 34 6 HET EEE A 35 6 HET EEE A 37 6 HET EEE A 38 6 HET EEE A 40 6 HET MOH A 42 2 HET EEE C 36 6 HET MOH C 39 2 HET EEE C 41 6 HET MOH C 43 2 HET MOH C 44 2 HET MOH C 45 2 HETNAM DVA D-VALINE HETNAM DPL 4-OXOPROLINE HETNAM SAR SARCOSINE HETNAM MVA N-METHYLVALINE HETNAM PXZ 2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO- HETNAM 2 PXZ PHENOXAZIN-3-ONE HETNAM EEE ETHYL ACETATE HETNAM MOH METHANOL HETSYN PXZ PHENOXAZINE FORMUL 1 DVA 6(C5 H11 N O2) FORMUL 1 DPL 3(C5 H7 N O3) FORMUL 1 SAR 6(C3 H7 N O2) FORMUL 1 MVA 6(C6 H13 N O2) FORMUL 1 PXZ 3(C16 H12 N2 O4) FORMUL 4 EEE 7(C4 H8 O2) FORMUL 9 MOH 5(C H4 O) LINK C THR A 1 N DVA A 2 1555 1555 1.34 LINK OG1 THR A 1 C MVA A 5 1555 1555 1.35 LINK N THR A 1 C0 PXZ A 6 1555 1555 1.36 LINK C DVA A 2 N DPL A 3 1555 1555 1.35 LINK C DPL A 3 N SAR A 4 1555 1555 1.34 LINK C SAR A 4 N MVA A 5 1555 1555 1.35 LINK C0' PXZ A 6 N THR A 7 1555 1555 1.34 LINK C THR A 7 N DVA A 8 1555 1555 1.36 LINK OG1 THR A 7 C MVA A 11 1555 1555 1.35 LINK C DVA A 8 N PRO A 9 1555 1555 1.34 LINK C PRO A 9 N SAR A 10 1555 1555 1.35 LINK C SAR A 10 N MVA A 11 1555 1555 1.35 LINK C THR B 1 N DVA B 2 1555 1555 1.34 LINK OG1 THR B 1 C MVA B 5 1555 1555 1.34 LINK N THR B 1 C0 PXZ B 6 1555 1555 1.36 LINK C DVA B 2 N DPL B 3 1555 1555 1.35 LINK C DPL B 3 N SAR B 4 1555 1555 1.35 LINK C SAR B 4 N MVA B 5 1555 1555 1.34 LINK C0' PXZ B 6 N THR B 7 1555 1555 1.35 LINK C THR B 7 N DVA B 8 1555 1555 1.34 LINK OG1 THR B 7 C MVA B 11 1555 1555 1.35 LINK C DVA B 8 N PRO B 9 1555 1555 1.34 LINK C PRO B 9 N SAR B 10 1555 1555 1.34 LINK C SAR B 10 N MVA B 11 1555 1555 1.34 LINK C THR C 1 N DVA C 2 1555 1555 1.34 LINK OG1 THR C 1 C MVA C 5 1555 1555 1.34 LINK N THR C 1 C0 PXZ C 6 1555 1555 1.35 LINK C DVA C 2 N DPL C 3 1555 1555 1.34 LINK C DPL C 3 N SAR C 4 1555 1555 1.36 LINK C SAR C 4 N MVA C 5 1555 1555 1.36 LINK C0' PXZ C 6 N THR C 7 1555 1555 1.34 LINK C THR C 7 N DVA C 8 1555 1555 1.36 LINK OG1 THR C 7 C MVA C 11 1555 1555 1.35 LINK C DVA C 8 N PRO C 9 1555 1555 1.33 LINK C PRO C 9 N SAR C 10 1555 1555 1.35 LINK C SAR C 10 N MVA C 11 1555 1555 1.34 CISPEP 1 DVA A 2 DPL A 3 0 12.34 CISPEP 2 DPL A 3 SAR A 4 0 5.47 CISPEP 3 DVA A 8 PRO A 9 0 20.19 CISPEP 4 PRO A 9 SAR A 10 0 -13.49 CISPEP 5 DVA B 2 DPL B 3 0 14.18 CISPEP 6 DPL B 3 SAR B 4 0 -8.76 CISPEP 7 DVA B 8 PRO B 9 0 21.75 CISPEP 8 PRO B 9 SAR B 10 0 -6.92 CISPEP 9 DVA C 2 DPL C 3 0 14.94 CISPEP 10 DPL C 3 SAR C 4 0 -12.58 CISPEP 11 DVA C 8 PRO C 9 0 13.27 CISPEP 12 PRO C 9 SAR C 10 0 -4.65 SITE 1 AC1 6 THR A 1 THR A 7 EEE A 35 EEE A 37 SITE 2 AC1 6 SAR B 10 EEE C 36 SITE 1 AC2 6 DVA A 8 EEE A 34 EEE A 38 DVA C 2 SITE 2 AC2 6 DPL C 3 EEE C 36 SITE 1 AC3 3 MVA A 5 EEE A 34 MVA C 5 SITE 1 AC4 6 DVA A 2 THR A 7 PRO A 9 MVA A 11 SITE 2 AC4 6 EEE A 35 MVA C 5 SITE 1 AC5 5 DPL A 3 DPL B 3 THR C 1 PXZ C 6 SITE 2 AC5 5 EEE C 41 SITE 1 AC6 4 DPL A 3 EEE A 34 EEE A 35 MVA C 5 SITE 1 AC7 5 EEE A 40 MVA B 5 DPL C 3 THR C 7 SITE 2 AC7 5 PRO C 9 SITE 1 AC8 14 EEE A 34 EEE A 35 EEE A 37 EEE A 38 SITE 2 AC8 14 EEE A 40 PXZ B 6 THR B 7 PRO B 9 SITE 3 AC8 14 MVA B 11 DPL C 3 SAR C 4 MVA C 5 SITE 4 AC8 14 PXZ C 6 EEE C 36 SITE 1 AC9 14 THR A 1 PXZ A 6 THR A 7 PRO A 9 SITE 2 AC9 14 MVA A 11 EEE A 34 EEE A 40 DVA C 2 SITE 3 AC9 14 PXZ C 6 DVA C 8 PRO C 9 SAR C 10 SITE 4 AC9 14 MVA C 11 EEE C 41 SITE 1 BC1 16 DVA A 2 DPL A 3 SAR A 4 PXZ A 6 SITE 2 BC1 16 EEE A 35 EEE A 37 EEE A 38 EEE A 40 SITE 3 BC1 16 DVA B 2 DPL B 3 MVA B 5 PXZ B 6 SITE 4 BC1 16 DVA B 8 MVA B 11 EEE C 36 EEE C 41 CRYST1 15.594 16.009 25.322 86.23 85.16 69.65 P 1 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.064127 -0.023785 -0.004506 0.00000 SCALE2 0.000000 0.066623 -0.002598 0.00000 SCALE3 0.000000 0.000000 0.039663 0.00000